Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Five Cheap Tech Stocks Poised to Gain

Page 1 of 2

While the biotech industry still undergoing a correction that started in the second half of 2015, the technology sector has once again replaced it as the top destination for growth investor to park their money. Both these sectors performed extremely well in the period between 2012 and 2015. However, their performance started diverging in 2015 and has gone in completely opposite direction this year. Whereas the NASDAQ 100 Technology Sector has registered a gain of 15.28% so far in 2016, the NASDAQ Biotechnology Index is down 14.43% year-to-date.

With the outperformance that the technology sector is displaying, it’s natural that institutional investors are making a beeline for tech stocks, pushing their prices even higher. However, this has caused a problem for small investors, many of whom can’t afford to invest in a stock like, Inc., which trades for $780 per share currently.  To solve that problem for our readers, we at Insider Monkey decided to compile a list of tech stocks that are trading below $10 per share right now, but can significant upside going forward as they were quite popular among hedge funds covered by us going into the third quarter. In this post, we will take a look at the five stocks that topped our list and discuss how they have performed this year.

We track hedge funds and prominent investors because our research has shown that historically their stock picks delivered superior risk-adjusted returns. This is especially true in the small-cap space. The 15 most popular small-cap stocks delivered a monthly alpha of 80 basis points in our backtests that covered the period between 1999 and 2012 (see the details here).

3g, business, tablet, digital, technology, of, analysing, professional, electronic, work, using, device, online, wireless, screen, businessman, website, network, browsing,

#5 Extreme Networks, Inc (NASDAQ:EXTR)

– Hedge Funds with Long Positions (as of June 30): 16

– Value of Hedge Funds’ Holdings (as of June 30): $47.41 Million

Let’s start with Extreme Networks, whose ownership among hedge funds covered by us remained unchanged during the second quarter, but the aggregate value of their holdings rose marginally by 1.6%. Though shares of the network infrastructure equipment provider took a beating at the beginning of 2016, they have managed to recoup all those losses since then and are currently trading up by 2.17% year-to-date. For its most recent quarter, the company reported EPS of $0.10, in-line with analysts’ expectation, and revenue of $141.89 million, which was $1.89 million above the estimates. On September 15, several analysts upped their price targets on the stock, including analysts at Wunderlich, who increased it to $6 from $5, reaffirming their ‘Buy’ rating.

Follow Extreme Networks Inc (NASDAQ:EXTR)
Trade (NASDAQ:EXTR) Now!

#4 Bazaarvoice Inc (NASDAQ:BV)

– Hedge Funds with Long Positions (as of June 30): 17

– Value of Hedge Funds’ Holdings (as of June 30): $93.28 Million

Though the ownership of Bazaarvoice among hedge funds tracked by us inched down by one during the second quarter, the aggregate value of their positions jumped by 21.3% over the quarter. Bazaarvoice Inc (NASDAQ:BV)’s stock is currently trading up by 9.03% year-to-date, owing largely to the 19% rally it has since the beginning of this month after the company released its fiscal 2017 first quarter numbers. While analysts had expected the company to report a loss of $0.04 per share on revenue of $48.97 million for the quarter, Bazaarvoice declared flat EPS on revenue of $50.1 million. On September 12, analysts at B. Riley reiterated their ‘Buy’ rating and $8 price target on the stock, which represents a potential upside of 61.6% from its current price.

Follow Bazaarvoice Inc (NASDAQ:BV)
Trade (NASDAQ:BV) Now!

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!